PUPAE SINGULATOR AND SEX SORTER

(19)

(11)

EP 3 996 500 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.10.2024 Bulletin 2024/42

(45)	Mention of the grant of the patent:
	04.09.2024 Bulletin 2024/36

(21)	Application number: 20836341.6

(22)	Date of filing: 10.07.2020

(51)

International Patent Classification (IPC):

A01K 67/033^(2006.01)
G06V 10/00^(2022.01)
B07C 5/342^(2006.01)

G06Q 50/02^(2024.01)
A01K 29/00^(2006.01)
B07C 5/36^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A01K 29/00; A01K 67/033; B07C 5/342; B07C 5/36; G06V 10/764

(86)	International application number:
	PCT/US2020/041657

(87)	International publication number:
	WO 2021/007541 (14.01.2021 Gazette 2021/02)

(54)	PUPAE SINGULATOR AND SEX SORTER PUPPENVEREINZELER UND GESCHLECHTSSORTIERER SÉPARATEUR DE NYMPHES ET DISPOSITIF DE SEXAGE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

11.07.2019 US 201962872844 P
09.07.2020 US 202016924885

(43)	Date of publication of application:
	18.05.2022 Bulletin 2022/20

(60)	Divisional application:
	24190563.7 / 4446021

(73)	Proprietor: Verily Life Sciences LLC
	Dallas, TX 75019 (US)

(72)	Inventor:
	GREELEY, Daniel San Francisco, California 94080 (US)

(74)	Representative: Mewburn Ellis LLP
	Aurora Building Counterslip Bristol BS1 6BX Bristol BS1 6BX (GB)

(56)

References cited: :

EP-A1- 3 430 900
US-A- 3 223 237
US-A1- 2012 061 240
US-B2- 10 342 222
US-B2- 9 242 219

WO-A1-2019/078785
US-A- 6 143 496
US-B1- 8 025 027
US-B2- 7 452 725

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).